Samsung Xincai replied to the regulatory letter: there is no direct or indirect misappropriation of raised funds through entrusted loans
Samsung Xincai replied to the regulatory letter, saying that the company's long-term large-scale external entrusted loans are reasonable, and there is no direct or indirect misappropriation of funds raised through entrusted loans.
This text is a result of machine translation.
Related companies：
In-depth
Jan 30, 2026 06:00 PM
Dec 11, 2023 08:49 PM
Jan 06, 2023 08:30 AM
Nov 16, 2022 05:19 PM
Briefing Jun 13, 2022 09:44 AM
· Healthcare
Cro plate fell, and Wuxi apptec fell nearly 10%
Briefing Jun 08, 2022 10:53 AM
· Consumer Staples
Baijiu stocks continued to rise
Briefing Jun 08, 2022 10:19 AM
· Technology
The oil and gas sector surged and strengthened, and the new energy 2 link board
Briefing Jun 08, 2022 09:43 AM
· Technology
Ruilan automobile sold 4030 units in May, up more than 30% month on month
Briefing Jun 08, 2022 07:24 AM
Rush to raise funds at a low price and build positions quickly. Multiple new funds are settled and raised in advance
Briefing Jun 07, 2022 10:14 PM
· Technology
Heilongjiang: accurately implement financial policies and accelerate the listing of enterprises
Briefing Jun 07, 2022 08:38 PM
· Technology
Maohua Shihua: purchased 69% of the equity of simvoda ocean with RMB 420million
Healthcare
CRO ClinChoice Raises USD 150 Mn in Series E Round
2015 is the inflection point for the development of China's innovative drug industry and CRO (clinical research organization). On July 22nd, 2015, after CDE (Center For Drug Evaluation) released the announcement on self-examination and verification of drug clinical trial data, the supervision of Chinese clinical trials moved towards standardization. The investment and financing of innovative drugs in China continued to increase, laying the foundation for the growth of CRO.
Jul 05, 2022 08:17 PM
Briefing Jun 07, 2022 08:04 PM
· Technology
Shengbang shares: it is proposed to participate in the investment and establishment of a partnership with RMB 40million
Briefing Jun 01, 2022 09:23 AM
American officials: the United States plans to expand its diplomatic presence in the Indian Pacific Region
Briefing May 31, 2022 05:39 PM
· Technology
GlaxoSmithKline will spend $3.3 billion to acquire the biopharmaceutical company affinivax
See more
Read next
Insight
In-depth
Technology · Interview
Exclusive Interview: NAVEE GOLF Is Building a Smart Golf Ecosystem, Starting with Push Carts
Yesterday 05:04 PM
Insight
In-depth
Embodied AI · Analysis
Chinese Embodied AI Company AI² Robotics: The Real Bottleneck in Embodied AI Is Scenarios, Not Just AI
Apr 14, 2026 11:25 AM
Insight
In-depth
Technology, Embodied AI · Analysis
From 0 to 2.6 million units, Ecovacs Window Robot makes "first choice" the only answer.
Apr 10, 2026 07:00 PM
Insight
In-depth